Results 191 to 200 of about 596,620 (345)

Marked variation in eligibility criteria across registrational trials for relapsed diffuse large B‐cell lymphoma limits applicability to clinical practice

British Journal of Haematology, EarlyView.
Summary Therapeutic options for relapsed or refractory diffuse large B‐cell lymphoma (rDLBCL) have expanded following accelerated approvals based largely on surrogate end‐points, yet confirmatory studies have not consistently reproduced these benefits across all agents, and outcomes for many patients remain poor.
Elizabeth Goodall, Jodie Palmer, Arina Martynchyk, Niamh Waters, Fiona Swain, Tran Binh Giang, Tamara Marconi, Jamie Brennan, Gareth P. Gregory, Chan Cheah, Colm Keane, Eliza A. Hawkes   +11 more
wiley   +1 more source

The prognostic significance of PFS24 in follicular lymphoma following firstline immunotherapy: A combined analysis of 3 CALGB trials [PDF]

, 2019
Barak, Ian, Bartlett, Nancy L, Blum, Kristie A, Cheson, Bruce D, Czuczman, Myron, Hsi, Eric, Jung, Sin-Ho, Lansigan, Frederick, Leonard, John P, Martin, Peter, Pitcher, Brandelyn, Schöder, Heiko, Smith, Scott   +12 more
core   +1 more source

Optical genome mapping improves detection and characterisation of cytogenetic abnormalities in non‐Hodgkin lymphomas

British Journal of Haematology, EarlyView.
Optical genome mapping (OGM) is feasible on fresh and frozen tissue lymphoma samples and demonstrated its added value for accurate diagnostic classification. OGM surpasses karyotype and FISH in refining diagnoses of lymphoma, identifying class‐defining rearrangements along with prognostic markers.
Coura Fall, Agnès Daudignon, Séverine Valmary‐Degano, Julie Mondet, Lucile Bussot, Lysiane Molina, Simon Chevalier, Edouard Bonneville, Pierre Aubert, Sylvie Tondeur, Clémentine Legrand, Jean‐Baptiste Gaillard, Hélène Guermouche, Anouk Emadali, Sylvain Carras, Christine Lefebvre   +15 more
wiley   +1 more source

Skin lesions as the first manifestation of follicular lymphoma

Przegląd Dermatologiczny, 2023
Julia Nowowiejska, Anna Baran, Iwona Flisiak   +2 more
doaj   +1 more source

Nontranslocation follicular lymphoma mimicking infectious mononucleosis: a diagnostic challenge in a 39-year-old male. [PDF]

Oxf Med Case Reports
Barsh E, Keeling J, Pang CS, Sattler R, Feustel K, Enurah A.   +5 more
europepmc   +1 more source

Covalent drug discovery: Progress against key targets, emerging strategies and lessons learnt

British Journal of Pharmacology, EarlyView.
Abstract Covalent drug discovery is currently experiencing a boom in industrial and academic interest. To date, at least 75 covalent drugs have received regulatory approval, targeting both traditional target classes and more challenging proteins for which other approaches failed. In many cases, unique aspects of covalent targeting are essential for the
Charles P. Brown, Alan Armstrong, David J. Mann   +2 more
wiley   +1 more source

Aggressive Recurrent Bilateral Chylothorax Secondary to Follicular Lymphoma in an HIV-Positive Patient: A Case Report and Clinical Implications. [PDF]

Cureus
Jagra AS, Ali R, Klukowicz A, Sharma HO, Miller R.   +4 more
europepmc   +1 more source

Evolving Pathology of Anaplastic Thyroid Carcinoma: Integrating Morphology, Immunohistochemistry, and Molecular Insights

Cancer Science, EarlyView.
Schematic overview of progression from differentiated thyroid carcinoma (DTC) to anaplastic thyroid carcinoma (ATC). ATC primarily develops via two pathways: the BRAF p.V600E‐mutated papillary thyroid carcinoma (PTC) pathway and the RAS‐mutated pathway. The origin and progression of BRAF/RAS‐wildtype ATC remain unclear.
Toru Odate, Tetsuo Kondo
wiley   +1 more source

Chylous Ascites: A Rare Initial Presentation of High-Grade Follicular Lymphoma. [PDF]

Case Rep Oncol Med
Nada R, Gvajaia A, Raza A, Raji M.
europepmc   +1 more source

Follicular lymphoma of the duodenum [PDF]

Endoscopy, 2007
P, Born, M, Vieth, M, Stolte
openaire   +2 more sources